Article Text
PDF
Other content recommended for you
- Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2
- Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers
- How to do it: How to get the most out of cerebrospinal fluid cytology
- Diagnosis and management of leptomeningeal disease secondary to grade IV astrocytic glioma
- Rapidly progressive dementia and ataxia in an elderly man
- Primary diffuse leptomeningeal gliomatosis diagnosed on CSF cytology: perseverance pays off
- Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies
- Diagnostic challenges in neoplastic meningitis presenting as intracranial hypertension
- Leptomeningeal metastases of a well-differentiated neuroendocrine tumour: a rare entity
- Isolated leptomeningeal carcinomatosis and possible fungal meningitis as late sequelae of oesophageal adenocarcinoma